← Browse by Condition
Medical Condition

neoplasm plasma cell

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT04776330 Phase 1, Phase 2
Recruiting

a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease

Enrollment
80 pts
Location
China
Sponsor
Chongqing Precision Biotech Co...
View Trial →